SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
134.256 1.31 (0.97%)

NAV as on 24 Apr, 2015

CRISIL MF RANK

Not Ranked

Scheme Risk Grade

  HIGH RISK

HIGH RISK

  • For investors looking at long term capital growth investments.
  • Ideal for people who wish to benefit from potentially higher returns and have the risk appetite for the same.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Mar 31, 15)
Equity Sector Value
(Rs cr)
Assets %
Sun Pharma Pharmaceuticals 80.84 22.99
Lupin Pharmaceuticals 49.90 14.19
Aurobindo Pharm Pharmaceuticals 34.46 9.80
Ranbaxy Labs Pharmaceuticals 30.66 8.72
Strides Arcolab Pharmaceuticals 22.19 6.31
Divis Labs Pharmaceuticals 21.59 6.14
Cadila Health Pharmaceuticals 20.96 5.96
Natco Pharma Pharmaceuticals 19.87 5.65
Torrent Pharma Pharmaceuticals 18.36 5.22
Alembic Pharma Pharmaceuticals 9.21 2.62
Sector Allocation (Mar 31, 15)
  Sector   % 1-Year
High Low

Pharmaceuticals

97.00 99.60 91.57
Asset Allocation (%) (Mar 31, 15)
Class
%

Equity

97.00

Others / Unlisted

0.14

Debt

0.00

Mutual Funds

N.A

Money Market

3.23

Cash / Call

-0.37

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

62.01

Top 10

87.60
Sectors
%

Top 3

97.00
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.